QJH-51277-01714
3 vaccinations
3 coded responses
34 check-ins
3 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 618 / IL
- Registered
- 2021-11-06
- Relationship
- Child or adolescent in my care
- Guardian
- ZVG-15006-98580
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-06
Registered in v-safe
-
2021-11-06
Dose 1 — Pfizer-BioNTech
- 2021-11-06
- 2021-11-07
- 2021-11-08
- 2021-11-09
- 2021-11-10
- 2021-11-11
- 2021-11-12
- 2021-11-13
- 2021-11-20
-
2021-11-28
Survey response — day 21, dose 1, dependentMedDRA: Rhinorrhoea — Feeling: FairFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
-
2021-12-04
Dose 2 — Pfizer-BioNTech
- 2021-12-04
-
2021-12-05
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-12-06
- 2021-12-07
- 2021-12-08
- 2021-12-09
- 2021-12-10
- 2021-12-11
- 2021-12-18
- 2021-12-27
- 2022-01-01
- 2022-01-09
- 2022-01-15
-
2022-03-05
Survey response — 3 months, dose 2, dependentMedDRA: Cough, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: GoodFree text: Had a runny nose and chest cough for 3-4 days. No fever. At home Covid test was negative. No apparent residual problems.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-27
Dose 3 — Pfizer-BioNTech
- 2022-05-31
- 2022-06-01
- 2022-06-02
- 2022-06-03
- 2022-06-11
- 2022-06-17
- 2022-06-24
- 2022-07-01
- 2022-07-10
-
2022-11-25
Survey response — 6 months, dose 3, dependentMedDRA: Cough, Pyrexia, Respiratory tract congestion — Feeling: FairFree text: Congestion, mild fever, coughMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-06 | Pfizer-BioNTech | No |
| 2 | 2021-12-04 | Pfizer-BioNTech | No |
| 3 | 2022-05-27 | Pfizer-BioNTech | No |
Free text
Release 10 — day 21, dose 1, dependent
Symptoms: Runny nose
Release 11 — 3 months, dose 2, dependent
Symptoms: Had a runny nose and chest cough for 3-4 days. No fever. At home Covid test was negative. No apparent residual problems.
Release 12 — 6 months, dose 3, dependent
Symptoms: Congestion, mild fever, cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release